Comparison of Amitriptyline to Lifestyle Modification as Intervention for Vestibular Migraine
Launched by VANDERBILT UNIVERSITY MEDICAL CENTER · May 11, 2024
Trial Information
Current as of February 19, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
1.0 Background
Vestibular migraine (VM) is one of the most common causes of vertigo attacks, affecting 1 - 5% of people. People with vestibular migraine have lower quality of life compared to others and some may experience completely debilitating symptoms. Symptoms include vertigo, nausea, head motion-induced dizziness, unsteadiness, balance problems, and lightheadedness. Most reports of vestibular migraine management have focused on treatment with medications; however, the investigators have shown that intervention with lifestyle modification is also effective.
1.1 Lifestyle Modification...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • English-speaking adults
- • Diagnosed with Definite Vestibular Migraine
- • Currently prescribed rescue medication for migraine is acceptable
- Exclusion Criteria:
- • Non-English speaking
- • Diagnosed and undergoing treatment for active Definite Meniere's disease
- • Already using amitriptyline
- * Contraindicated for intervention with amitriptyline including:
- • Patients with Hepatic Impairment
- • Patients with Renal Impairment
- • Pregnancy
- • Breastfeeding
- • Elderly Patients
- • Allergy to amitriptyline
- • Heart attack
- • Used an MAO inhibitor in the past 14 days
- • Used an "SSRI" antidepressant in the past 5 weeks
- • Bipolar disorder (manic-depression) or schizophrenia
- • Mental illness or psychosis
- • Stroke
- • Seizures
- • Diabetes
- • Glaucoma
- • Problems with urination
Trial Officials
Richard A Roberts, PhD
Principal Investigator
Vanderbilt University Medical Center
About Vanderbilt University Medical Center
Vanderbilt University Medical Center (VUMC) is a leading academic medical center located in Nashville, Tennessee, renowned for its commitment to advancing healthcare through innovative research and clinical excellence. As a prominent sponsor of clinical trials, VUMC integrates cutting-edge scientific inquiry with patient-centered care, supporting a diverse array of studies aimed at enhancing medical knowledge and improving treatment outcomes. With a robust infrastructure and a multidisciplinary team of experts, VUMC fosters collaboration across various fields, ensuring the highest standards of safety and ethical considerations in its research endeavors. Through its dedication to medical discovery and education, VUMC plays a pivotal role in shaping the future of medicine.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Nashville, Tennessee, United States
Nashville, Tennessee, United States
People applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Discussion 0